Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Blood|September 23, 2011
A phase 2 multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphomaTodd A Fehniger, Sarah Larson, Kathryn Trinkaus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2017
Lack of a Prognostic Impact of the MyD88 L265P Mutation for Diffuse Large B Cell Lymphoma Patients Undergoing Autologous Stem Cell TransplantationYi-Shan Lee, Jingxia Liu, Kristine A Fricano, et al.
Hematological Oncology|January 10, 2017
Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma-a "real world" studyNarendranath Epperla, Mehdi Hamadani, Amanda F Cashen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 15, 2013
Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimenShivaprasad Manjappa, Pavan Kumar Bhamidipati, Keith E Stokerl-Goldstein, et al.
Med (New York, N.Y.)|May 19, 2022
A Systemic Protein Deviation Score Linked to PD-1+ CD8+ T Cell Expansion That Predicts Overall Survival in Diffuse Large B Cell LymphomaEivind Heggernes Ask, Astrid Tschan-Plessl, Thea Johanne Gjerdingen, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 25, 2018
Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment RegimenNirav N Shah, Aniko Szabo, Raya Saba, et al.
Blood|January 9, 2017
Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphomaKilannin Krysiak, Felicia Gomez, Brian S White, et al.
Blood Neoplasia|June 24, 2025
BIRC5 upregulation enhances DNMT3A-mutant T-ALL cell survival and pathogenesisWangisa Dunuwille, William C Wilson, Hassan Bjeije, et al.
British Journal of Haematology|February 2, 2022
Impact of conditioning regimen intensity on the outcomes of peripheral T-cell lymphoma, anaplastic large cell lymphoma and angioimmunoblastic T-cell lymphoma patients undergoing allogeneic transplantMalvi Savani, Kwang W Ahn, Yue Chen, et al.
Cancers|June 24, 2022
Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell LymphomaShama Jaswal, Vanessa Sanders, Priyanka Pullarkat, et al.
Pageof 10